Geleijnse M L, Elhendy A, van Domburg R T, Cornel J H, Reijs A E, Roelandt J R, Krenning E P, Fioretti P M
Thoraxcentre, University Hospital Rotterdam-Dijkzigt, The Netherlands.
J Am Coll Cardiol. 1996 Aug;28(2):447-54. doi: 10.1016/0735-1097(96)00149-0.
This study investigated the prognostic value of dobutamine-atropine technetium-99m (Tc-99m) sestamibi single-photon emission computed tomographic (SPECT) myocardial perfusion imaging.
Dobutamine-atropine Tc-99m sestamibi SPECT imaging is an accurate method for the detection of coronary disease. However, the prognostic value of this stress modality has not been assessed.
Three hundred ninety-two consecutive patients with chest pain (mean [+/- SD] age 60 +/- 12 years; 220 men, 190 with a previous myocardial infarction) underwent a dobutamine-atropine Tc-99m sestamibi SPECT scintigraphic study. Patients were followed up for 22 +/- 13 months to determine the univariate and multivariate variables associated with hard cardiac events (cardiac death, nonfatal myocardial infarction), to define their event-free survival and to determine whether the extent and severity of reversible perfusion defects correlated with events.
Forty-four patients (11%) had hard cardiac events. Multivariate models demonstrated that older age (odds ratio [OR] 2.1, 95% confidence interval [CI] 1.0 to 4.4), history of heart failure (OR 2.6, 95% CI 1.3 to 5.2), abnormal sestamibi scan results (OR 10.0, 95% CI 2.3 to 43.0) and reversible perfusion defects (OR 3.2, 95% CI 1.6 to 6.4) had independent predictive value. Patients without perfusion defects, with fixed defects alone, reversible defects alone and fixed plus reversible defects had annual hard cardiac event rates of 0.8%, 6.8%, 8.1% and 11.6%, respectively. Patients with increasing reversible defect scores had increasing annual event rates of 2.1%, 5.0%, 5.5%, 13.0% and 14.6%, respectively.
Dobutamine-atropine stress Tc-99m sestamibi SPECT imaging provides excellent prognostic information. The single most important independent predictor for future hard cardiac events is an abnormal pattern, and a reversible defect provides additional, independent prognostic information. Moreover, the extent and severity of reversible defects are major determinants for prognosis.
本研究调查了多巴酚丁胺 - 阿托品负荷99m锝(Tc - 99m)甲氧基异丁基异腈单光子发射计算机断层扫描(SPECT)心肌灌注成像的预后价值。
多巴酚丁胺 - 阿托品负荷Tc - 99m甲氧基异丁基异腈SPECT成像是检测冠心病的一种准确方法。然而,这种负荷方式的预后价值尚未得到评估。
392例连续胸痛患者(平均年龄[±标准差]60±12岁;男性220例,其中190例有既往心肌梗死病史)接受了多巴酚丁胺 - 阿托品负荷Tc - 99m甲氧基异丁基异腈SPECT闪烁扫描研究。对患者进行了22±13个月的随访,以确定与严重心脏事件(心源性死亡、非致死性心肌梗死)相关的单变量和多变量因素,定义其无事件生存率,并确定可逆性灌注缺损的范围和严重程度是否与事件相关。
44例患者(11%)发生了严重心脏事件。多变量模型显示,年龄较大(比值比[OR]2.1,95%置信区间[CI]1.0至4.4)、心力衰竭病史(OR 2.6,95%CI 1.3至5.2)、甲氧基异丁基异腈扫描结果异常(OR 10.0,95%CI 2.3至43.0)和可逆性灌注缺损(OR 3.2,95%CI 1.6至6.4)具有独立的预测价值。无灌注缺损、仅有固定性缺损、仅有可逆性缺损以及固定性加可逆性缺损的患者,其年度严重心脏事件发生率分别为0.8%、6.8%、8.1%和11.6%。可逆性缺损评分增加的患者,其年度事件发生率分别为2.1%、5.0%、5.5%、13.0%和14.6%。
多巴酚丁胺 - 阿托品负荷Tc - 99m甲氧基异丁基异腈SPECT成像可提供出色的预后信息。未来严重心脏事件的最重要独立预测因素是异常模式,而可逆性缺损可提供额外的独立预后信息。此外,可逆性缺损的范围和严重程度是预后的主要决定因素。